Valuation: Labcorp Holdings Inc.

Market Cap 30.19B 27.04B 24.9B 22.64B 42.83B 2,836B 43.99B 298B 119B 1,517B 113B 111B 4,792B P/E 2026 *
27.4x
P/E 2027 * 24.7x
Enterprise Value 35.36B 31.67B 29.17B 26.51B 50.16B 3,321B 51.52B 349B 139B 1,776B 133B 130B 5,612B EV / Sales 2026 *
2.38x
EV / Sales 2027 * 2.23x
Free-Float
99.65%
Yield 2026 *
0.78%
Yield 2027 * 0.79%
1 day-0.26%
1 week+4.30%
Current month+2.63%
1 month+18.81%
3 months+16.20%
6 months+45.95%
Current year+47.83%
1 week 355.63
Extreme 355.63
373.76
1 month 310.11
Extreme 310.11
373.76
Current year 245
Extreme 245
373.76
1 year 245
Extreme 245
373.76
3 years 191.97
Extreme 191.97
373.76
5 years 191.97
Extreme 191.97
373.76
10 years 98.02
Extreme 98.02
373.76
Date Insider Type Main position Quantity % Market Cap. Importance
3/11/26 Sell

EVP and President, Diagnostics

-306 0.0004%
2/11/26 Tax

EVP and President, Diagnostics

-194 0.0002%
2/11/26 Tax

Chief Technology Officer

-118 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.26%+4.30%+46.76%+81.55% 30.19B
+4.41%+0.56%+12.69%+33.37% 109B
-0.09%+7.84%+5.83%+121.66% 105B
-2.62%-17.67%+56.33%+587.33% 46.46B
+1.18%+8.03%+10.16%+105.72% 33.1B
-0.47%+3.04%+43.98%+96.32% 28.57B
+0.44%+7.95%+41.42%+451.22% 23B
+0.23%+1.42%-17.61%-15.87% 19.97B
+0.52%-1.40%-6.52%+30.30% 16.76B
+4.83%+9.40%+118.74% - 14.41B
Average +0.82%+1.60%+31.18%+165.73% 43B
Weighted average by Cap. +1.08%+1.05%+23.00%+152.79%

Financials

2026 *2027 *
Net sales 14.83B 13.28B 12.23B 11.12B 21.03B 1,393B 21.6B 146B 58.32B 745B 55.65B 54.46B 2,353B 15.63B 13.99B 12.89B 11.71B 22.16B 1,467B 22.77B 154B 61.46B 785B 58.64B 57.39B 2,480B
Net income 1.11B 995M 917M 833M 1.58B 104B 1.62B 10.97B 4.37B 55.83B 4.17B 4.08B 176B 1.22B 1.09B 1B 913M 1.73B 114B 1.77B 12.02B 4.79B 61.16B 4.57B 4.47B 193B
Net Debt 5.17B 4.63B 4.26B 3.88B 7.33B 485B 7.53B 51.01B 20.33B 260B 19.4B 18.98B 820B 4.59B 4.11B 3.79B 3.44B 6.52B 431B 6.69B 45.34B 18.07B 231B 17.24B 16.87B 729B
Projected Income Statement - Annual - Labcorp Holdings Inc.
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
10/11/26 USD 370.88 -0.26% 509,947
09/11/26 USD 371.83 +1.43% 797,777
06/11/26 USD 366.57 +0.90% 610,114
05/11/26 USD 363.30 -1.22% 775,272
04/11/26 USD 367.79 +3.92% 809,673
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Labcorp Holdings Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
371.83USD
Average target price
390.06USD
Spread / Average Target
+4.90%